| |
|
|
| Issue 15: December 12, 2003 |
|
Issue 14: December 5, 2003 |
 |
| Kenneth S. Abramowitz,
Senior Advisor, The Carlyle Group, on the impact of Medicare
reforms on the HMO industry. |
|
|
 |
| Anthony Robbins, M.D.,
Professor of Public Health, Tufts University School of Medicine,
on Medicare reform in historical perspective. |
|
|
|
| Issue 12: November 21, 2003 |
|
Issue 11: November 14, 2003 |
 |
| Louis M. Solomon,
Partner, Proskauer Rose LLP, on Hatch-Waxman reforms. |
|
|
 |
| Sharon Treat, Senate
Majority Leader, State of Maine, on Maine’s initiatives
to lower the cost of prescription drugs. |
|
|
|
| Issue 10: November 7, 2003 |
|
Issue 9: October 31, 2003 |
 |
| Nick Naclerio, President,
ParAllele BioSciences, on pushing the boundaries of high-throughput
SNP genotyping. |
|
|
 |
| Vibeke Strand, M.D.,
Adjunct Clinical Professor, Division of Immunology, Stanford
University, on new treatment therapies for rheumatiod arthritis. |
|
|
|
| Issue 7: October 17, 2003 |
|
Issue 6: October 10, 2003 |
 |
| Christopher D. Hook,
Director for RFID Market Development & Deborah H. Murphy,
Life Sciences Market Development Manager, Zebra Technologies,
on technologies for pharmaceutical supply chains. |
|
|
 |
| Brian G. Atwood,
Managing Director, Versant Ventures, on biotech venture capital
investing and market cycles. |
|
|
|
| Issue 5: October 3, 2003 |
|
Issue 4: September 26, 2003 |
 |
| Glenn Rice,
Vice President for Biopharmaceutical Sciences, SRI International,
on bridging the gap from university research labs to clinical
trials. |
|
|
 |
| Eric Lindsey, Vice
President for Business Development, PDI Inc., on salesforce
outsourcing. |
|
|
|
| Issue 3: September 19, 2003 |
|
Issue 2: September 12, 2003 |
 |
| Jack Trout, President,
Trout & Partners, Ltd., on product positioning through
DTC advertising. |
|
|
 |
| Tom Heyman, Executive
Vice President for Business Development, Johnson & Johnson,
on J&J’s in-licensing activities. |
|
|
|
| Issue 1: September 5, 2003 |
|
|
 |
| Paula Campbell Evans,
Partner, Palmer & Dodge LLP, on the regulatory prospects
for generic biologics. |
|
|
|
| 2003 | 2004 |
Copyright © 2003-2004 Michael Solomon Associates, Inc. All Rights Reserved.
